Skip to main content

Cannabis Watch: The No. 1 Reason Adults Support Legalizing Marijuana (it’s Not To Get High)

The vast majority of people who support marijuana legalization aren’t looking to just get high, a new poll finds.

In fact, 86% of supporters cite the drug’s benefits to those who use it medicinally as a “very important” reason they favor legalization, according to a Gallup poll of more than 1,000 U.S. adults conducted between May 15 and May 30.

There is evidence that cannabis and/or cannabinoids can help with conditions like pain, multiple sclerosis-related muscle spasms and chemotherapy-related nausea, according to a 2017 research review by the National Academies of Science, Engineering and Medicine.

Other reasons respondents deemed “very important” included freeing up law enforcement to focus on other types of crime (70%), marijuana use being a matter of personal choice and freedom (60%), providing a tax-revenue source for state and local governments (56%), increased safety for marijuana users due to government regulation (47%), and the belief that marijuana isn’t harmful to users (35%).

Sixty-four percent of respondents thought marijuana ought to be legalized, 34% said it should be illegal and 2% had no opinion. As for why opponents didn’t want marijuana legalized, nearly eight in 10 said the potential increase in marijuana-involved car accidents was a “very important” reason for their disapproval. Additional top reasons included the notion that marijuana was a gateway to stronger and more addictive drugs (69%) and the possibility that more people would use marijuana (62%).

See also: More baby boomers use medical marijuana, but they want their doctors to get wise to the risks and benefits

Gallup’s main finding tracks with a recent survey by market-research firm Nielsen, which found that one in three U.S. adults aged 21 and up were interested in using legalized cannabis, and those who said they’d consume the drug if it were legalized were most likely to cite pain treatment and other wellness-related reasons.

Top reasons cited for potential cannabis consumption included treatment of chronic pain (85%), mental-health improvement (82%), treatment of minor injuries (81%), sleep aid (77%) and relaxation (74%).

Additional sources of interest in consuming cannabis included treatment of a non-pain medical condition (63%), disease or ailment prevention (60%), improvement of physical health (58%) and having a good time with friends and family (48%). Enhancement of spirituality rounded out the bottom of the list, at 28%.

See also: What a 30-day break from smoking marijuana does to your brain

What’s more, around four in 10 people who have headache or migraine pain (40%), people who have arthritic pain (40%) and people who have back and neck pain (41%) expressed an interest in cannabis consumption.

A majority of folks who would use cannabis and have an ailment said they already used an over-the-counter or prescription medication to treat it. Such ailments include headaches and migraines, back and neck pain, arthritis pain, “feminine pain,” general aches and pains, trouble falling asleep and cancer pain.

As for why cannabis-curious adults who use other medications would weigh the psychoactive drug to treat their symptoms, seven in 10 perceived it to be more effective than over-the-counter or prescription options, and 67% thought it was healthier. Sixty-nine percent, meanwhile, said cannabis seemed “more natural.”

Thirty-four U.S. states and the District of Columbia have legalized medicinal marijuana use, and 10 states and the District of Columbia have legalized recreational use. Lawmakers in New York and New Jersey are also considering legalizing recreational use, though recent efforts appear to have stalled.

This widespread marijuana legalization tracks with Americans’ steadily rising support over the past several decades: 62% think marijuana use should be made legal, according to a 2018 Pew Research survey, up from 31% in 2000 and just 16% in 1990. Some 65% of Americans now consider smoking marijuana to be morally acceptable, recent Gallup polling has found.

Meanwhile, the legal cannabis market continues to grow at a rapid pace. It was worth about $8.3 billion in 2017 and will reach nearly $25 billion by 2025, according to 2018 estimates by the cannabis-industry data and analytics firm New Frontier Data.

Market leader Canopy Growth Corp. CGC, -0.26%   is up 57.7% for the year to date, while Aurora Cannabis Inc. ACB, -0.39%   is up 54.4%. That’s compared to an 11.4% increase for the Dow Jones Industrial Average DJIA, -0.17%   and a 14.8% increase for the S&P 500 SPX, -0.20%   over the same period.

This story was originally published June 5, 2019, and has been updated.

Original Article Source: http://www.marketwatch.com/news/story.asp?guid=%7BB192B022-87AD-11E9-80CD-84377CB8CC30%7D&siteid=rss&rss=1

Comments

Post a Comment

Popular posts from this blog

Mormon Church Faces Potential Lawsuit Over Medical Marijuana Opposition

Political committees concerned with marijuana law reform in four states have waged an information war over the past year, first to qualify cannabis initiatives for the ballot, and then to support or oppose those measures in the lead-up to last week’s midterm elections. In total, over  $12.9 million in cash and in-kind services was spent attempting to convince voters about these marijuana ballot measures. Now that voters have had their say, Marijuana Moment decided to calculate how much each “yes” and “no” vote cost the committees on either side of the debate. Our calculations are based on dollars raised and disclosed before the election, since final totals of actual expenditures won’t be available until December or January reports required in the states that voted on cannabis. Michigan In Michigan, where voters approved marijuana legalization , our calculations show that the two anti-legalization committees spent about $1.28 per “no” vote, as they raised $2.37 million for ...
Post a Comment
Read more

Dixie Brands To Enter Oklahoma Marijuana Market Through Deal With Globus

Dixie Brands, a Denver-based consumer packaged goods company, said it is entering the Oklahoma medical cannabis market through a manufacturing and distribution agreement with Globus Holdings. Oklahoma marks the sixth state where Dixie has operations. The company trades on the Canadian Securities Exchange under the ticker symbol  DIXI . There are roughly 130,000 medical marijuana patients in Oklahoma, where voters approved a ballot measure in June 2018. For more details about the agreement, click here . Get access to more in-depth market analysis, premium features on cannabis investing trends and monthly executive webcasts with an  Investor Intelligence subscription . Original Article Source: https://mjbizdaily.com/dixie-brands-enters-oklahoma-marijuana-market-through-deal-with-globus/
Post a Comment
Read more

NY Dem Chair Warns Against Passing Voter-Supported Marijuana Legalization Bill

The head of New York’s Democratic Party said on Thursday that if the state Senate votes on a marijuana legalization bill, his party’s lawmakers run the risk of alienating voters and losing reelection next year. Jay Jacobs, the state party chairman, claimed that several “far progressive” measures, including cannabis legalization, lack popularity in certain areas across the state such as Long Island and upstate New York. He cautioned lawmakers against putting the issue to a vote, arguing that voters would “throw us out of office.” “It could be the straw that breaks the camel’s back,” he told Newsday. Polling doesn’t support that conclusion, though. According to a March 2019 survey from Quinnipiac, 65 percent of New Yorkers are in favor of allowing adults to legally possess cannabis for personal use. That includes 63 percent of respondents in upstate New York and 65 percent of those living in the suburbs. Sixty-six percent of independents statewide also back ending marijuana prohibit...
Post a Comment
Read more